Adamas Pharmaceuticals, Inc. EBITDA 2014-2021 | ADMS
Adamas Pharmaceuticals, Inc. ebitda from 2014 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Adamas Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-43 |
| 2019 | $-92 |
| 2018 | $-115 |
| 2017 | $-86 |
| 2016 | $-60 |
| 2015 | $-56 |
| 2014 | $17 |
| 2013 | $57 |
| 2012 | $20 |
| Adamas Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-09-30 | $-5 |
| 2021-06-30 | $-9 |
| 2021-03-31 | $-9 |
| 2020-12-31 | $-15 |
| 2020-09-30 | $-9 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $-13 |
| 2019-12-31 | $-21 |
| 2019-09-30 | $-24 |
| 2019-06-30 | $-21 |
| 2019-03-31 | $-26 |
| 2018-12-31 | $-25 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-30 |
| 2018-03-31 | $-31 |
| 2017-12-31 | $-28 |
| 2017-09-30 | $-22 |
| 2017-06-30 | $-20 |
| 2017-03-31 | $-16 |
| 2016-12-31 | $-15 |
| 2016-09-30 | $-15 |
| 2016-06-30 | $-17 |
| 2016-03-31 | $-14 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-15 |
| 2015-06-30 | $-14 |
| 2015-03-31 | $-12 |
| 2014-12-31 | $16 |
| 2014-09-30 | $-10 |
| 2014-06-30 | $17 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $35 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $27 |
